Final week, the primary Hashish Well being Symposium to happen in Germany noticed the native trade’s main telemedicine and pharmacy voices pull aside the rationale behind proposed medical hashish restrictions.
Representatives from throughout Germany’s thriving medical hashish sector, together with Grünhorn Group, Bloomwell Group, and the Affiliation of Hashish-Supplying Pharmacies, challenged the federal government’s assertions of widespread abuse, criticised their lack of engagement with the sector, and argued that such restrictions would impression essentially the most susceptible.
This spirited debate comes because the trade is asking out for readability on what restrictions, if any, will finally be carried out following greater than a 12 months of hostile rhetoric from federal officers.
These proposed amendments stay in legislative limbo. If pushed by, they might require in-person consultations for preliminary hashish prescriptions and ban mail-order pharmacies from supplying hashish.
For now, the package deal has been blocked contained in the governing coalition by the SPD, with Carmen Wegge saying the occasion won’t approve it as drafted and Matthias Mieves publicly campaigning for hashish telemedicine platforms. Commerce press now places the earliest real looking choice at late autumn or winter 2026. Prohibition Companions has warned the package deal may shrink the German market by as a lot as 50% if it passes in its present type.
Operators who’ve crossed the road
The opening panel, Telemedicine: Revolution or Danger, introduced collectively Tobias Bosse of Grünhorn Group, Dr Christiane Neubauer of the Verband Hashish-versorgender Apotheken (VCA, the Affiliation of Hashish-Supplying Pharmacies), and Dr Julian Wichmann of Bloomwell Group. It adopted a solo knowledge presentation from Grünhorn’s knowledge lead, Patrick Mobius, whose figures underpinned a number of of the panel’s arguments.
From the offset, the panel made it clear that they don’t dispute vital points dogging the sector. Bosse acknowledged that the ministry has had lots to level at, citing a leak of 1.7m affected person information at a telemedicine operator, platforms which have based their very own political occasion to defend their enterprise mannequin, and platforms which have licensed the names and faces of German rappers to market prescriptions by Instagram.
“That’s extra merch than medication,” he mentioned. Grünhorn’s personal check ordering, Bosse added, had discovered platforms with no age verification, no identification verification, no amount caps, ‘most likely nearly automated prescription releases inside seconds’, and prescribing networks primarily based overseas whose licensing just isn’t traceable from Germany.
With this in thoughts, nonetheless, he asserted that your entire trade shouldn’t be held accountable for the actions of a subset of particular, identifiable unhealthy actors.
“There’s a spike in demand, and to derive from that that it’s all abusive is a improper evaluation,” he mentioned.
His colleague’s earlier presentation laid out the size of the impression these proposed modifications would have. Grünhorn mapped each cannabis-distributing pharmacy in Germany towards inhabitants density and located that 70.1 million individuals, greater than 80% of the nation, reside additional than 20km from a specialised pharmacy.
This offers a measure of the share of the market whose prescriptions at present attain them by mail-order relatively than walk-in assortment. For aged sufferers, shift employees, carers, these with out automobiles and the significantly unwell, that friction is the distinction between remaining on a prescription and falling off it and probably returning to the black market.
The pharmacy view
Neubauer, whose affiliation represents the specialist pharmacies that truly fulfil hashish prescriptions, mentioned the mannequin is already beneath compounding stress from operators.
Pharmacy chambers are issuing steerage asking pharmacists to ascertain how every prescription was generated, whether or not there was a questionnaire or video session, ample anamnesis or not.
“That isn’t our job. I wish to make that completely clear,” she mentioned. “We can not, we could not, and the affected person doesn’t should reply us. These are delicate knowledge, and in that second they’re none of our enterprise.”
Pharmacies working with the extra aggressive telemedicine platforms, she mentioned, at the moment are being accused of complicity in violations of the medical promoting legislation by cooperating with operators providing zero-euro prescriptions and heavy advertising and marketing.
The second compounding stress is worth. “It’s fantastic {that a} affected person pays €2.99 per gram for flower,” she continued, “however when the pharmacist, after platform charges, has barely any margin left on that gram, the sums don’t add up.
“That can go very badly improper, as a result of pharmacies usually solely discover late that income just isn’t the identical as revenue.” She pointed to the latest insolvency submitting by specialist hashish pharmacy Lux 99 in Hürth as the primary seen casualty of that squeeze.
This worth stress can also be being pushed by a flood of latest merchandise getting into the market. In his presentation earlier that morning, Mobius defined that Germany’s specialist hashish pharmacies now carry greater than 2,000 distinct flower strains, and the highest 20 importers alone account for 77% of merchandise on the shelf and 88% of market share by Grünhorn’s personal definitions.
Neubauer believes that past the industrial implications, this inflow of merchandise is having a medical impression.
“That makes no therapeutic sense,” she asserted. “It’s full insanity. Studying a few of this product advertising and marketing, you’re feeling like you might be studying a wine menu. For me, that has nothing extra to do with medication.”
‘We hear concerning the abuse, we see no measurable penalties’
Whereas the panel was clear on the problems dealing with the biggest medical hashish market in Europe, it challenged the federal government’s repeated accusations of ‘abuse’, alongside assertions it represented a menace to public well being.
“We hear concerning the abuse, however we see no measurable penalties,” Wichmann mentioned, pointing to flat hospitalisation charges amongst hashish sufferers, flat traffic-accident charges, and a Frankfurt police president who had informed the group straight that the pressure had ‘had good experiences’ with hashish sufferers.
He additionally challenged the premise that an in-person prescription is mechanically safer than a telemedicine one. Bloomwell’s personal analysis, Wichmann mentioned, has discovered statutory-insurance sufferers receiving prescriptions of as much as 800 grams of hashish per thirty days from a single prescribing doctor, far above something a telemedicine platform with identification and age verification would problem.
“Telemedicine just isn’t much less secure,” he mentioned. “It’s merely extra seen.”
Bloomwell has fought instances on Germany’s medical promoting legislation so far as the Federal Court docket of Justice. The March 2026 ruling in Bloomwell’s favour clarified what’s permitted however left telemedicine platforms unable to debate indications.
As such, platforms can not inform sufferers which situations hashish flower may assist deal with, on the courtroom’s reasoning that sufferers may seek the advice of the medication’s package deal insert as a substitute. Hashish flower has no package deal insert, and the ministry publishes no indications database of its personal. Sufferers in search of the knowledge find yourself in casual discussion groups.
Business excluded from discussions
As the federal government coalition continues its inner tug-of-war on limiting the trade, the panellists all contended they have been being not noted of the dialog.
Wichmann mentioned Bloomwell had obtained a cancellation from CDU Basic Secretary Carsten Linnemann for a scheduled assembly on the morning of the symposium itself. Dialogue conferences had run routinely beneath the earlier SPD-led ministry of Karl Lauterbach, however beneath CDU Well being Minister Nina Warken, they haven’t.
Bloomwell had individually approached statutory and personal well being insurers at board degree with a pilot proposal to reimburse hashish prescriptions through telemedicine in a regional pain-therapy cohort. Each insurer declined.
Regardless, every put ahead their very own suggestions for reform primarily based on their front-line expertise. The primary was a certification regime for telemedicine platforms protecting age and identification verification, minimal session requirements, documentation necessities and acceptable prescriber jurisdictions.
Second, Neubauer argued for the long-stalled Pillar 2 of the cannabis-legalisation framework, a direct authorized retail route for adult-use hashish by pharmacies, with THC and amount caps and correct counselling. Present telemedicine volumes, she mentioned, are partly a symptom of grownup customers with no authorized different route. Bosse known as Pillar 2 ‘utopian’ given Berlin’s present political local weather however didn’t rule it out as a long-term decision.
Whether or not any of this reaches the ministry is the open query. On Bloomwell’s personal survey knowledge cited on the panel, greater than 40% of German hashish sufferers mentioned they might flip to the black market if the mail-order ban passes.
